Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(9%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
10
91%
Ph phase_2
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Other(2)

Detailed Status

Completed5
Not yet recruiting3
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (9.1%)
N/A10 (90.9%)

Trials by Status

unknown218%
not_yet_recruiting327%
completed545%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DEVICE
Total Trials
11